Association between use of desloratadine and risk of seizures, supraventricular tachycardia, and atrial fibrillation or flutter: A Nordic register-based study (MK-4117-205) First published 06/07/2020 Last updated 24/05/2024 EU PAS number:EUPAS35911 Study Finalised